Bench to Bedside Speakers


Suchismita Acharya
Suchismita Acharya, PhD
CEO, AyuVis Research Inc
Assistant Professor, North Texas Eye Research Institute
Pharmacology & Neuroscience, UNT Health Science Center

Thomas Chalberg
Thomas W. Chalberg, PhD
Founder, Polymerase Capital
Founder, Exhaura Ltd.
Executive Chairman, iRenix

Louis Cullman
Louis C. Cullman, Esq.
Partner, K&L Gates, LLP

Alon Harris
Alon Harris, MS, PhD, FARVO
Department of Ophthalmology, Icahn School of Medicine at Mount Sinai

Thurein Htoo
Thurein Htoo, MS, MBS
Qlaris Bio, Inc.
Starlight Bio, Inc.

Darius Kharabi
Darius Kharabi, JD, MBA

Chief Business Officer at Kala Pharmaceuticals

Saho Murakami
Saho Murakami, MD
Office of New Drug Ⅲ, Pharmaceuticals and Medical Devices Agency (PMDA)

Tieuvi Nguyen
Tieuvi Nguyen, PhD
Director, Division of Ophthalmic Devices, FDA

Susan Orr
Susan Orr
CMO, Claris Biotherapeutics

Hema Ramkumar
Hema Ramkumar, MD
CEO, Oculogenex 

Stella Robertson
Stella Robertson, PhD, FARVO
Arrochar Consulting, LLC; Bios Partners, LP

Cynthia Toth
Cynthia A. Toth, MD
Joseph AC Wadsworth Professor of Ophthalmology and Professor of Biomedical Engineering, Duke University
Chief Medical Officer, Theia Imaging LLC


Register for B2B
Secure your spot for the 2023 B2B Meeting
B2B sponsorship information
View the high-impact opportunities available to promote your brand throughout the Bench to Bedside Meeting